Development and targeting of transcriptional regulatory network controlling FLU1 activation in Candida albicans for...

Area of Science:

• Mycology
• Molecular Biology
• Computational Chemistry

Background:

• Candidiasis, primarily caused by Candida albicans, presents a significant threat due to multidrug resistance.
• Current antifungal strategies are often ineffective against resistant strains, necessitating novel therapeutic approaches.

Purpose of the Study:

• To elucidate the regulatory interactions governing a major multidrug and toxic compound extrusion (MFS) transporter gene in Candida albicans.
• To identify the docking effects of antifungal compounds on the transcription factor regulating the FLU1 gene.
• To develop a predictive map for controlling gene expression at initial levels for antifungal drug development.

Main Methods:

• In silico analysis of regulatory interactions controlling the FLU1 gene in Candida albicans.
• Molecular docking simulations to assess the interaction between antifungal compounds and the target transcription factor.
• In silico ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) analysis for pharmacokinetic assessment.

Main Results:

• Identification of key regulatory factors controlling the FLU1 gene, suitable as targets for antifungal agents.
• Docking results demonstrated a favorable interaction between tested compounds and the target transcription factor.
• Positive in silico ADMET results indicated favorable pharmacokinetic properties for potential antifungal compounds.

Conclusions:

• In silico studies provide a valuable approach for understanding and targeting significant genes in Candida albicans to combat drug resistance.
• The identified targets and compounds show promise for developing new antifungal therapies with improved efficacy.
• Computational methods, including docking and ADMET analysis, are crucial for refining and selecting effective drug candidates.